Compare Medpace Holdings Inc (MEDP) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs United Parcel Service Inc — how do they compare? Medpace Holdings Inc trades at $602 (market cap $16.82B), while United Parcel Service Inc trades at $94.41 (market cap $80.08B). The key difference: United Parcel Service Inc is far larger — about 4.8× Medpace Holdings Inc's market cap, and United Parcel Service Inc pays a 6.97% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and United Parcel Service Inc for 141 Days on average.
| MEDP | UPS | |
|---|---|---|
Market Cap | $16.82B | $80.08B |
Volume | 223,093 | 6,706,833 |
Sector | Health | Industrials |
52-Week High | $630.19 | $120.00 |
52-Week Low | $393.42 | $82.87 |
Typical Hold Time | 14 Days | 141 Days |
Enterprise Value | $16.44B | $104.10B |
Dividend Yield | — | 6.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $604.25, up 0.22% with neutral technical signals and strong fundamental performance. The stock shows robust profitability with 17.67% net income margin and consistent earnings beats in recent quarters. Recent news highlights institutional activity including CEO stock sales and upcoming Q3 2026 earnings report on October 21, 2026. Technical indicators show mixed signals with RSI neutral and ADX bullish, while support sits at $589 and resistance at $629.
MEDP presents a mixed outlook with strong fundamentals offset by high valuations and insider selling. The 21% buy rating from analysts suggests cautious optimism, with $620.44 price target offering 2.7% upside. Key risks include elevated P/E ratio of 35.5 and recent CEO stock sales totaling over $44 million in September 2026. Positive cash flow projection for 2026 supports growth potential despite current net outflow.
UPS trades at $92.28, down 0.89% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with a P/E of 17.15 and ROE of 29.66%, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership.
The outlook is mixed: analyst consensus price target of $118.67 suggests 29% upside, but technical indicators and recent downgrades highlight near-term pressure. Key risks include fuel costs, domestic volume concerns, and Amazon competition, while the 7% dividend yield provides income support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
